Abstract: A server includes a hard disk carrier, a wire arranging frame, and a cabinet having an accommodating space accommodating the hard disk carrier and the wire arranging frame. The hard disk carrier drives the wire arranging frame to be unfolded or folded in a length direction of the cabinet or in a thickness direction of the cabinet. The wire arranging frame includes a wire arranging frame body and a support member. The wire arranging frame body includes wire arranging arms hinged in sequence, and axes of rotation shafts between every two adjacent wire arranging arms are parallel to each other. The wire arranging arms include articulated arms located at a head end and a tail end of the wire arranging frame body and rotatably connected to the hard disk carrier and the cabinet. The support member is supported between the wire arranging arms and the bottom wall of the cabinet.

Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.

Abstract: The present invention provides a method of treating heart failure with reduced ejection fraction, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the anchoring of PP2A to mAKAP?. This composition is preferably in the form of a viral based gene therapy vector that encodes a fragment of mAKAP? to which PP2A binds.

Abstract: The present invention provides a method of treating heart failure with reduced ejection fraction, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the anchoring of PP2A to mAKAP?. This composition is preferably in the form of a viral based gene therapy vector that encodes a fragment of mAKAP? to which PP2A binds.

Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.

Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.

Abstract: The present invention discloses a jetting, expansion and extrusion combined pile, a construction method thereof and a spiral jetting, expansion and extrusion drilling rig used in the method. A pile of the combined pile comprises a pile body (101), an expanded body (103) and a pile end (106). At least one double-frustum-shaped expanded body (103), which is integrally formed with the pile body (101), is arranged on the pile body (101). The expanded body (103) is located in a vertical soil layer position, which has higher deformation modulus and shear strength, of the pile body (101), and at least two wing plates (102) which are uniformly distributed in the circumference direction and basically perpendicular to the axis of the pile are arranged on the pile body (101). The diameter of the pile above the expanded body (103) is larger than or equal to that of the pile below the expanded body (103).

Abstract: The present disclosure relates to an oil flow switch, comprising a float device connected to a circulating oil passage and a floating liquid level switch element provided in the float device, wherein the float device comprises an oil inlet, an oil outlet, and a float chamber provided between the oil inlet and the oil outlet, the floating liquid level switch element is provided in the float chamber, and the float device is provided with a channel in communication with the float chamber. The oil flow switch according to the present disclosure may avoid a false alarm of the oil level switch and meanwhile mitigate disturbance to the float caused by liquid level fluctuation to reduce friction between the float and the sleeve rod. Further, a lubrication system with the above oil.

Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.

Abstract: The present invention provides a method of treating heart failure with reduced ejection fraction, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the anchoring of PP2A to mAKAP?. This composition is preferably in the form of a viral based gene therapy vector that encodes a fragment of mAKAP? to which PP2A binds.

Abstract: A falling-film evaporator includes an evaporator cylinder, a mist eliminator disposed in the evaporator cylinder, a dispenser disposed in the evaporator cylinder, a liquid baffle disposed in the evaporator cylinder, a first chamber formed at least partially by the mist eliminator and the liquid baffle on a first side of the evaporator cylinder below the mist eliminator, a gas returning chamber formed at least partially by the mist eliminator and the liquid baffle on a second side of the evaporator cylinder above the mist eliminator, a gas-liquid separation chamber formed at least partially by the dispenser at an upper portion of the first chamber, and an evaporation chamber formed at least partially by the dispenser at a lower portion of the first chamber, and where the gas returning chamber is in fluid communication with the evaporation chamber.

Abstract: A ground wellhole dedicated protective pipe, disposed inside a ground wellhole for gas extraction of a mining-induced area, includes a casing, and a chain inside the casing and slidable relative to the casing. The chain includes a chain formed by a plurality of chain drums through serial connection, and a detachable connecting piece connecting between chains. A plurality of air holes is opened in the chain drum along an axial direction of the chain drum.

Abstract: The present invention discloses a jetting, expansion and extrusion combined pile, a construction method thereof and a spiral jetting, expansion and extrusion drilling rig used in the method. A pile of the combined pile comprises a pile body (101), an expanded body (103) and a pile end (106). At least one double-frustum-shaped expanded body (103), which is integrally formed with the pile body (101), is arranged on the pile body (101). The expanded body (103) is located in a vertical soil layer position, which has higher deformation modulus and shear strength, of the pile body (101), and at least two wing plates (102) which are uniformly distributed in the circumference direction and basically perpendicular to the axis of the pile are arranged on the pile body (101). The diameter of the pile above the expanded body (103) is larger than or equal to that of the pile below the expanded body (103).

Abstract: The present invention provides a method of treating heart failure with reduced ejection fraction, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the anchoring of PP2A to mAKAP?. This composition is preferably in the form of a viral based gene therapy vector that encodes a fragment of mAKAP? to which PP2A binds.

Abstract: A dynamically self-balancing pressurized borehole sealing apparatus and method thereof for coal seam gas pressure measurement having a pressure measuring tube arranged in a borehole with one end of the pressure measuring tube provided with a pressure measuring unit. The pressure measuring tube is wrapped with an expansion airbag and provided with a pressure introducing hole communicating with the expansion airbag. On each side of the expansion airbag, the pressure measuring tube is wrapped with a front borehole inflatable sealing airbag and a rear borehole inflatable sealing airbag respectively. A gel injection chamber is reserved between the front borehole sealing airbag and the rear borehole sealing airbag and between the expansion airbag and an inner side of the borehole. Gas from the pressure measuring tube expands the expansion airbag and squeezes sealing gel in the gel injection chamber into borehole fractures for dynamic pressurized sealing.

Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.

Abstract: Disclosed is a ground wellhole dedicated protective pipe for gas extraction of a mining-induced area. The ground wellhole dedicated protective pipe for gas extraction of a mining-induced area is disposed inside a ground wellhole for gas extraction of the mining-induced area and the ground wellhole dedicated protective pipe for gas extraction of a mining-induced area includes a casing and a chain that is disposed inside the casing and slidable relative to the casing, wherein the chain includes a plurality of chain drums and connecting pieces movably connecting the adjacent chain drums, and a plurality of air holes are opened in the chain drum along an axial direction of the chain drum.

Abstract: The present invention provides a method of protecting the heart from damage, by administering to a patient at risk of such damage, a pharmaceutically effective amount of a composition which inhibits the interaction of RSK3 and mAKAP?, or the expression or activity of one or both of those molecules. This composition may be in the form of a peptide that specifically inhibits mAKAP? binding to RSK3 or in the form of an siRNA construct which inhibits the expression of RSK3.

Abstract: Provided are a dynamically self-balancing pressurized borehole sealing apparatus and a method thereof for coal seam gas pressure measurement, wherein the dynamically self-balancing pressurized borehole sealing apparatus for coal seam gas pressure measurement comprises a pressure measuring tube arranged in a borehole, one end of the pressure measuring tube is provided with a pressure measuring unit for measuring a gas pressure, the pressure measuring tube is surrounded and wrapped with an expansion airbag, the pressure measuring tube is provided with a pressure introducing hole communicating with the expansion airbag, both sides of the expansion airbag on the pressure measuring tube are surrounded and wrapped with a front borehole sealing airbag and a rear borehole sealing airbag respectively, a gel injection chamber is reserved between the three of the front borehole sealing airbag, the rear borehole sealing airbag and the expansion airbag and an inner side of the borehole, the gel injection chamber is filled

Abstract: Embodiments of the present disclosure are directed toward a falling-film evaporator that includes an evaporator cylinder, a mist eliminator disposed in the evaporator cylinder, a dispenser disposed in the evaporator cylinder, a liquid baffle disposed in the evaporator cylinder, a first chamber formed at least partially by the mist eliminator and the liquid baffle on a first side of the evaporator cylinder below the mist eliminator, a gas returning chamber formed at least partially by the mist eliminator and the liquid baffle on a second side of the evaporator cylinder above the mist eliminator, a gas-liquid separation chamber formed at least partially by the dispenser at an upper portion of the first chamber, and an evaporation chamber formed at least partially by the dispenser at a lower portion of the first chamber, and where the gas returning chamber is in fluid communication with the evaporation chamber.